About
Building the future of high touch, high quality care.
Activity
10K followers
-
Tim Doyle posted thisEucalyptus has signed an agreement to be acquired by hims & hers. When the deal closes, we plan to build the best consumer health business in the world. I'll oversee the company’s international business. I think back to the launch of Hims & Hers as really the beginning of the patient-led transformation that healthcare has been undergoing for the last decade. Seeing a website that felt aspirational, low friction, clearly explained - with a payment model that was approachable - felt revolutionary at a time when the US healthcare system was everything but that. When we were launching Eucalyptus, we drew inspiration from Hims & Hers. So this feels full circle. As we look forward, this patients-first era of healthcare is only accelerating. It's become abundantly clear that in the future, patients will have a relationship with one or many digital clinics where they understand their own health data through regular tracking and diagnostics, use that information to interact with a variety of practitioners, and then take action across a wide range of their healthcare decisions. Hims & Hers is the best-positioned business in the world to be the home for consumer health. They've set the bar for what it means to be focused on the patient for the last decade — and as we accelerate toward the future, being part of what is fast becoming the leading global consumer health platform is extremely exciting. Of course, this is also a moment to look backward and say thank you - to our investors, staff, clinicians, partners and our patients. Eucalyptus started seven years ago as a bet that generalist talent from Australia could build a globally competitive consumer healthcare business. In many ways, this is the achievement of that aspiration. And as we look forward, our team now has the opportunity to be part of building one of the great healthcare businesses in the world — one that transforms hundreds of millions of lives.
-
Tim Doyle shared thisOur research team, working with Stanford, just published new findings from ~20,000 patients in the UK. As has been seen throughout our published research, long-term outcomes are driven by wrap-around support and sustained engagement. -Patients who met our adherence criteria saw 22.6% average weight loss at 12 months -Consistent weekly engagement was the strongest predictor of long-term success - Hyper-engagement early on (obsessive tracking, rapid early weight loss) was actually associated with lower long-term adherence That last one is really interesting to me. It reinforces something we've been focusing more on: pacing matters, expectation setting matters, and the care model needs to be something patients can actually sustain over years, not just the first few weeks. It's been great watching our clinical and product teams evolve how we support patients off the back of this kind of evidence. https://lnkd.in/gYjcKT8412-Month Weight Loss and Adherence Predictors in a Real-World UK Tirzepatide-Supported Digital Obesity Service: A Retrospective Cohort Analysis | MDPI12-Month Weight Loss and Adherence Predictors in a Real-World UK Tirzepatide-Supported Digital Obesity Service: A Retrospective Cohort Analysis | MDPI
-
Tim Doyle shared thisI've been working with the Roosters coaching team to think through the question of "how can we use the oncoming wave of new technology to win more Rugby League games" (an outcome close to my heart) The output of that is that they're on the hunt for a data engineer to help accelerate the analytical capability of the organisation. It's an incredible opportunity to have a real impact how decisions are made in an elite sporting organisation. There has been great work done bringing together messy data sources into something useful, but they have only really begun to scratch the surface of what is possible, and they are a curious and engaged organisation open to ways to get better. If you're an analytically minded data engineer looking for an interesting green field project to own end-to-end, this is a great opportunity. More broadly if you have ideas about how data eng, analytics and AI can win more games of rugby league, i'd love to hear them.Tim Doyle shared thisWe've got an exciting opportunity available to join our Club! ⭐ Data Engineer Join a high-performing organisation where data drives elite outcomes. Work with modern data platforms and help power decision-making on and off the field. Tech hints: AWS/Azure | SQL | Python | ETL | BI & Analytics Apply now: https://lnkd.in/g_fuSWgTData Engineer Job in Moore Park, Sydney NSW - SEEKData Engineer Job in Moore Park, Sydney NSW - SEEK
-
Tim Doyle reposted thisTim Doyle reposted thisLast week I sat down with Tim Doyle, CEO & Cofounder at Eucalyptus at our AGM. We talked about how Eucalyptus evolved from a house of brands to a healthcare platform expanding from Australia to the world. It’s rare to see a company scale creative marketing, clinical systems, and international operations with equal skill. Today, Eucalyptus is one of the largest, and fastest growing multi-market GLP-1 digital clinics in the world. They've published 20 peer-reviewed studies on the safety and efficacy of their obesity program. Their patients receive holistic care and observe superior outcomes. And they've nailed international expansion into the UK, Germany and Japan. We've been fortunate to partner with them since the Series B. Watching them go from local champion to global operator has been unreal. They're also hiring: https://lnkd.in/gRXCw3HV
-
Tim Doyle shared thisA common startup trope is that the best time to join a startup is right at the beginning. If it all works out, sure. You get the glory, the financial upside, the ride etc etc. But the reality is not this in most cases, your control of the trajectory of the company is pretty low, you’re taking a lot of risk you can’t control, and to be honest a lot of early startup work is boring, low influence, low complexity pain. So I want to make a (self-serving) argument that the real answer here is when a company inflects it's ambition. You want a company that has the capability, the infrastructure and the capital to take on a truly global problem. You want that company to have not yet solved the problem, and to have the humility to know that and to be looking for leaders who can be accountable drivers of solutions. You want the company to have the maturity to pay you properly, not post garbage about 9/9/6 and actually understand what it takes to build durability. We have spent the last few years getting to a point where we can credibly raise the ambition for our company. So I can credibly say now, there is no better opportunity for impact at scale in Australia. We have 100 open roles here. https://lnkd.in/gVEPUjdc If none of them look like you, but you have something to add, message me.Tim Doyle shared thisRyan Nolan explains Eucalyptus well here. Suffice to say, if this is you, now is a good time to join the team.
-
Tim Doyle shared thisIt is so clear that AI is going to bring a new golden age to creative marketing. The era of the arbitrage gremlins is over (bad news for me).Winning comes from ambitious storytelling not endless variants of mind numbing UGC. Everyone just needs to end the marketing culture wars and embrace it. Great to swap notes on this new era with the best marketer in VC (not a strong field)Tim Doyle shared thisIn this week's episode, we chatted with Tim Doyle from Eucalyptus Tim is an old friend and one of the rare performance-obsessed leaders who is also a true creative. What stood out in this conversation: - “There is no such thing as brand marketing,” only ambitious storytelling paired with rigorous measurement - Speed to learning as a primary KPI, smaller briefs and faster cycles that create more at-bats - A baseball scorecard for creative: singles to home runs. This shifts incentives from craft perfection to performance outcomes. - Lift tests and MMM as the default, click attribution as supporting evidence - Where AI adds real leverage in creative and ops, and where human taste must stay in the loop - How to foster more risk taking with scale, and ways to think about marketing risk
-
Tim Doyle reposted thisTim Doyle reposted thisWe're hiring for 2 Growth interns. Paid position, working full time, for a few months. You'll write, shoot, interview, edit, make content, experiment. You'll learn from experts, build new skillsets, get tonnes of feedback and make a difference. We've had some brilliant people come through the business recently as Ops Interns, and I want to replicate that in Growth. If you're keen to apply, send me a DM or email (angus@eucalyptus.vc) with a link to something you've made that you are proud of. It can be anything. --- I've spent most of my time at Euc working on the patient-facing operations side of the business, where we have thousands of daily interactions with patients. Now I'm working in Growth. It's new for me, but the challenge feels familiar: understand people's problems, and explain clearly and persuasively how we can help. How we do that for prospective patients (through ads, content, messaging) is different than how we do it for existing patients (e.g. through calls, chat, consults). But the intent is the same. It's fun, challenging, interesting. Not least because, unlike in Ops, the patient doesn't tell you the problem directly. You have to figure out the problem yourself, then try to meet them with something that resonates. --- If that challenge gets you going, you should apply for this role and come work with us. Just DM or email (angus@eucalyptus.vc) with something you've made that you're proud of.
-
Tim Doyle reposted thisTim Doyle reposted thisWe’re bringing together a new Australian Telehealth Standards Consortium to co-design national telehealth standards that put patients first. The consortium includes Australia’s leading telehealth providers, private health insurers, and digital health innovators, alongside patient voices and independent experts. Participating organisations include Healthdirect Australia, Medibank, HCF Australia, Bupa, nib Group's Honeysuckle Health, Updoc, Eucalyptus, Healthengine, MedAdvisor Solutions AU, Mosh, Medmate, 13SICK National Home Doctor, and Wesfarmers Health. Working closely with the The Royal Australian College of General Practitioners (RACGP) as a consultation partner, the group will develop practical, meaningful standards to improve the safety and quality of telehealth for all Australians. Chaired by our Digital Health Ambassador Richard Skimin, with the support of our CEO Lisa Robins, this is an initiative which is designed to ensure the future of telehealth is shaped by and for the people who use it, in partnership with experts and industry leaders. Read more in the media release below.
-
Tim Doyle shared thisThe longer I spend around high growth companies the more I realise that the challenge is mostly staying alive long enough to be exposed to moments of good luck, and then having the execution capability to capitalise on them. If you can do that, you get to start thinking about what the durable hundred year version of your business is, which is luckily enough what we get to do now. Had a great time with Ed Cowan talking scaling on the TDM Growth Partners podcast.Tim Doyle shared this“𝗪𝗲 𝗱𝗼𝗻’𝘁 𝘄𝗶𝗻 𝗯𝘆 𝗱𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗻𝗴 𝗺𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻. 𝗪𝗲 𝘄𝗶𝗻 𝗶𝗳 𝘄𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿 𝗱𝘂𝗿𝗮𝗯𝗹𝗲 𝗵𝗲𝗮𝗹𝘁𝗵 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀.” — Tim Doyle, CEO & Co-Founder, Eucalyptus After helping scale Koala into a household name, Tim Doyle turned his attention to something far more complex: healthcare. That idea became Eucalyptus — now a house of brands reshaping what consumer-first healthcare can look like. In this Scaling Up episode:: ✅ Why Euc’s edge isn’t distribution — it’s the care model wrapped around it ✅ Building teams like an professional sports team list manager- think salary cap, not org chart ✅ Scaling care across regulation, trust, and attention ✅ How the business was built to move fast from the beginning to take advanatge of healtcare trends ✅ Tim's own personal scaling journey as a young, outspoken CEO "𝗧𝗵𝗲 𝘀𝗸𝗶𝗹𝗹 𝗶𝘀 𝘀𝘁𝗮𝘆𝗶𝗻𝗴 𝗮𝗹𝗶𝘃𝗲 𝗹𝗼𝗻𝗴 𝗲𝗻𝗼𝘂𝗴𝗵 𝘁𝗼 𝗲𝘅𝗽𝗼𝘀𝗲 𝘆𝗼𝘂𝗿𝘀𝗲𝗹𝗳 𝘁𝗼 𝗹𝘂𝗰𝗸 — 𝗮𝗻𝗱 𝘁𝗵𝗲𝗻 𝗲𝘅𝗲𝗰𝘂𝘁𝗶𝗻𝗴 𝗶𝗻 𝗮 𝘄𝗼𝗿𝗹𝗱-𝗰𝗹𝗮𝘀𝘀 𝘄𝗮𝘆 𝘄𝗵𝗲𝗻 𝗶𝘁 𝗵𝗶𝘁𝘀." 🎧 Listen: https://lnkd.in/gVkQhd7m
-
Tim Doyle liked thisThe Locomotive Act of 1865 in the UK required self-propelled vehicles to have a three-person crew: a driver, a stoker, and a flagman. The flagman had to walk 60 yards ahead of the car holding a red flag to warn pedestrians that a car was coming. The Therapeutic Goods Administration trying to put the cat back in the bag on scribes looks about as logical as making a man with a flag walk in front of cars to placate the haters……Tim Doyle liked thisHow did AI scribes slip through the Therapeutic Goods Administration loophole? by Caitlin Wright. The TGA has admitted it’s reviewing all 200 AI scribes in the market. A key question is whether the scribes replace a clinical function. https://lnkd.in/gzfaQ6Bq
-
Tim Doyle liked thisNo one I’d rather have at the helm of our global ops than Josh Krueger! He’s already set the bar incredibly high and has put an operating structure in place that allows us to consistently prioritize both the safety of our customers and the efficiency of our business. As the newest member of our executive team, he’s going to play a huge role in what comes next for Hims & Hers. Congrats, Josh! Let’s keep building.Tim Doyle liked thisOver the past few years at hims & hers, I’ve had the opportunity to work alongside an amazing team that consistently takes on complex challenges, finding ways to build, scale, and deliver. That’s what makes this next chapter especially exciting: Today, I’m stepping into a new role as Global SVP, Operations. Titles aside, what matters most to me is the opportunity to lead an extraordinary team and what we’ve been able to build together. I’m incredibly proud of this group. I’m not one to brag, but what this team has accomplished is nothing short of extraordinary. Within just a few years, we’ve built compounding capabilities from the ground up and scaled into one of the largest operations of its kind, all while maintaining a strong focus on quality and minimizing defects. In just two years, we nearly doubled internal fulfillment, improving both speed and cost to serve. Along the way, we’ve taken on challenges that, at the time, felt anything but certain. Developing and launching new pharmacy capabilities in Arizona and Ohio, building a proprietary Pharmacy Management System within months, scaling rapidly to support unexpected demand in weight loss, and standing up new offerings like Labs and Diagnostics in record time. At the same time, we’ve begun extending these capabilities beyond the U.S., supporting our expansion into new markets like Canada and the UK, with more to come as we continue building toward a truly global platform. None of this happens without a team of true builders who lean into complexity, move with urgency, and stay grounded in delivering for our customers. Grateful for the trust, the partnership, and the team behind all of this. It’s been an incredible journey so far, and I’m energized by what we have the opportunity to build together next.
-
Tim Doyle liked thisTim Doyle liked thisGenuine question for GPs ... Have you ever wondered if there's a better way to spend the next decade of your career? We think there is ... and it doesn't require you to change what you do; just where you do it. Email or DM me if you want to build something more for yourself. Details below. ecgppartner101.netlify.app
-
Tim Doyle liked thisTim Doyle liked thisHitting your inbox this week… The definitive guide to traveling with GLP-1 medications and peptide therapies. Cold chain. TSA. International travel. Dosing logistics—covered. Subscribe (free) to one of the fastest-growing health newsletters on the internet: https://lnkd.in/gtjQSvF8
-
Tim Doyle liked thisTim Doyle liked thisWith Novo Nordisk now being Australia's largest pharmaceutical company by sales, we also represent a significant share of all Danish exports to Australia. It was a privilege, therefore, to be part of the "Danish Strongholds" track during this week's Royal and business delegation visit — a week excellently coordinated by the teams at the Embassy of Denmark in Australia and Danish Industry Tuesday's session gave my colleague Elin and me a rare opportunity to present our Australian activities directly to Her Majesty Queen Mary. We touched upon the partnerships announced the day prior, on our "Marie Krogh – Young Woman in Science" Award and also the €300 million grant from the Novo Nordisk Foundation (our controlling shareholder) supporting stem cell research 🧬 at MCRI. This week was a strong reminder of the depth of Danish-Australian 🇩🇰🇦🇺 relations. For anyone considering expanding their market and footprint — this country is well worth exploring.
-
Tim Doyle reacted on thisWarning - this is just local PHN bashing - I feel like I still need to remind the world that our PHN is useless so scroll on if this sounds boring…..also Wendy Machin I’m happy to be offered a seat on the board to fix it….just saying. This is exactly why I have no faith in my PHN to come up with grants. Take this one - on paper an ok idea - the PHN will help practices by providing sign up bonuses to expedited pathway GPs as a means of increasing workforce. Whatever - at least it’s something. But here’s where it gets dumb. So you don’t get the grant at the point of starting recruiting (nor any certainty that you will get a grant if you do recruit someone). Instead you need to go out, recruit someone, sign a contract and then MAYBE (if there’s any money left and you’re chosen) the GP will get $10k from the PHN. How is that a useful process?! So maybe if I’m lucky I might be able to give this GP a grant when they sign but I’ll have to wait and see. Richard Nankervis Hunter New England and Central Coast PHNTim Doyle reacted on this🚀 Demand has been strong with over 70% of grants allocated 🩺 Are you a practice that has a GP on the Expedited Specialist Pathway? Limited grants are available, applications close 31 May or until all grants are allocated - visit https://lnkd.in/gAuVPDZW to apply ✅Expedited Specialist Pathway Grants 2026 - Primary Health NetworkExpedited Specialist Pathway Grants 2026 - Primary Health Network
Experience & Education
-
Eucalyptus
View Tim’s full experience
See their title, tenure and more.
or
Other similar profiles
Explore more posts
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More